The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
ABC-06 | A randomised phase III, multi-centre, open-label study of Active Symptom Control (ASC) alone or ASC with oxaliplatin / 5-FU chemotherapy (ASC+mFOLFOX) for patients (pts) with locally advanced / metastatic biliary tract cancers (ABC) previously-treated with cisplatin/gemcitabine (CisGem) chemotherapy.
 
Angela Lamarca
Honoraria - Eisai; Nutricia; Nutricia (I)
Speakers' Bureau - Ipsen; Ipsen (I); Merck; Novartis (I); Pfizer; Pfizer (I)
Research Funding - Ipsen; Ipsen (I)
Travel, Accommodations, Expenses - Abbott Nutrition; Advanced Accelerator Applications; Bayer; Celgene; Delcath Systems; Ipsen; Ipsen (I); Mylan; NanoString Technologies (I); Novartis; Pfizer; Sirtex Medical
 
Daniel H. Palmer
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD; Nucana; Sirtex Medical
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; MSD; Nucana; Sirtex Medical
Research Funding - AstraZeneca; Bayer; Bristol-Myers Squibb; Nucana; Sirtex Medical
 
Harpreet Singh Wasan
Honoraria - Array BioPharma; Celgene; ERYTECH Pharma; Merck KGaA; Roche/Genentech; Servier; Shire; Sirtex Medical
Consulting or Advisory Role - ERYTECH Pharma; Incyte; Roche Pharma AG; Shire; Sirtex Medical
Speakers' Bureau - Celgene; Merck KGaA; SERVIER; Sirtex Medical
Research Funding - Merck KGaA (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Sirtex Medical (Inst)
 
Paul J. Ross
Honoraria - Bayer; Celgene; Merck Serono; Roche
Consulting or Advisory Role - Amgen; Baxalta; Bristol-Myers Squibb; Celgene; Sirtex Medical
Research Funding - Sanofi
Travel, Accommodations, Expenses - Amgen; Bayer; Celgene; Merck Serono; SERVIER
 
Yuk Ting Ma
Honoraria - Bayer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst)
Travel, Accommodations, Expenses - Bayer
 
Arvind Arora
No Relationships to Disclose
 
Stephen Falk
Speakers' Bureau - Merck Serono; Merck Serono; Merck Serono
Research Funding - Gilead Sciences (Inst)
Travel, Accommodations, Expenses - Celgene
 
Roopinder Gillmore
No Relationships to Disclose
 
Jonathan Wadsley
Honoraria - Eisai; Genzyme
Speakers' Bureau - Eisai; Genzyme
Research Funding - AstraZeneca; Genzyme
Travel, Accommodations, Expenses - Celgene; Genzyme; Imaging Equipment Limited; Ipsen
 
Kinnari Patel
No Relationships to Disclose
 
Alan Anthoney
Consulting or Advisory Role - Novartis
 
Anthony Maraveyas
Honoraria - Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Pfizer
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Pfizer
Speakers' Bureau - Bayer; Bristol-Myers Squibb
Research Funding - Bayer; Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; EUSA Pharma
 
Justin S. Waters
Travel, Accommodations, Expenses - Ipsen
 
Claire Hobbs
Travel, Accommodations, Expenses - Varian Medical Systems
 
Safia Barber
No Relationships to Disclose
 
David Ryder
No Relationships to Disclose
 
John Ramage
Speakers' Bureau - Advanced Accelerator Applications; Ipsen; Novartis
Research Funding - Advanced Accelerator Applications; Ipsen; Novartis
 
Linda M Davies
No Relationships to Disclose
 
John A. Bridgewater
Honoraria - Merck Serono; SERVIER
Consulting or Advisory Role - AstraZeneca; Basilea; Bayer; Incyte; Merck Serono; Merck Serono; Roche; SERVIER
Speakers' Bureau - Amgen; Celgene
Research Funding - Amgen
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Bristol-Myers Squibb/Medarex; Merck Serono; MSD Oncology; SERVIER
 
Juan W. Valle
Honoraria - Ipsen
Consulting or Advisory Role - Agios; AstraZeneca; Delcath Systems; Genoscience Pharma; Incyte; Ipsen; Keocyt; Merck; Mundipharma; Novartis; PCI Biotech; Pfizer; Pieris Pharmaceuticals; QED Therapeutics
Speakers' Bureau - Imaging Equipment Limited; Ipsen; Novartis; Nucana
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Nucana